Global Remimazolam Supply, Demand and Key Producers, 2024-2030

Global Remimazolam Supply, Demand and Key Producers, 2024-2030

Page: 109

Published Date: 29 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Remimazolam market size is expected to reach $ 619.7 million by 2030, rising at a market growth of 5.1% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Remimazolam, sold under the brand name Byfavo, is a medication for the induction and maintenance of procedural sedation in adults for invasive diagnostic or surgical procedures lasting 30 minutes or less. is a benzodiazepine drug, developed by PAION AG in collaboration with several regional licensees as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in the induction of anesthesia and conscious sedation for minor invasive procedures. Remimazolam was found to have both a more rapid onset and a shorter duration than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.

This report studies the global Remimazolam production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Remimazolam, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Remimazolam that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Remimazolam total production and demand, 2019-2030, (K Units)
Global Remimazolam total production value, 2019-2030, (USD Million)
Global Remimazolam production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Remimazolam consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Remimazolam domestic production, consumption, key domestic manufacturers and share
Global Remimazolam production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Remimazolam production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Remimazolam production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Remimazolam market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Paion, Yichang Renfu Pharmaceutical, Jiangsu Hengrui Medicine, Cosmo Pharmaceuticals, Mundipharma, Pharmascience and Hana Pharm, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Remimazolam market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Remimazolam Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Remimazolam Market, Segmentation by Type
2.5mg
20mg

Global Remimazolam Market, Segmentation by Application
Surgical Anesthesia
ICU Sedation
Other

Companies Profiled:
Paion
Yichang Renfu Pharmaceutical
Jiangsu Hengrui Medicine
Cosmo Pharmaceuticals
Mundipharma
Pharmascience
Hana Pharm

Key Questions Answered
1. How big is the global Remimazolam market?
2. What is the demand of the global Remimazolam market?
3. What is the year over year growth of the global Remimazolam market?
4. What is the production and production value of the global Remimazolam market?
5. Who are the key producers in the global Remimazolam market?
btl

Table of Contents

1 Supply Summary
1.1 Remimazolam Introduction
1.2 World Remimazolam Supply & Forecast
1.2.1 World Remimazolam Production Value (2019 & 2023 & 2030)
1.2.2 World Remimazolam Production (2019-2030)
1.2.3 World Remimazolam Pricing Trends (2019-2030)
1.3 World Remimazolam Production by Region (Based on Production Site)
1.3.1 World Remimazolam Production Value by Region (2019-2030)
1.3.2 World Remimazolam Production by Region (2019-2030)
1.3.3 World Remimazolam Average Price by Region (2019-2030)
1.3.4 North America Remimazolam Production (2019-2030)
1.3.5 Europe Remimazolam Production (2019-2030)
1.3.6 China Remimazolam Production (2019-2030)
1.3.7 Japan Remimazolam Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Remimazolam Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Remimazolam Major Market Trends

2 Demand Summary
2.1 World Remimazolam Demand (2019-2030)
2.2 World Remimazolam Consumption by Region
2.2.1 World Remimazolam Consumption by Region (2019-2024)
2.2.2 World Remimazolam Consumption Forecast by Region (2025-2030)
2.3 United States Remimazolam Consumption (2019-2030)
2.4 China Remimazolam Consumption (2019-2030)
2.5 Europe Remimazolam Consumption (2019-2030)
2.6 Japan Remimazolam Consumption (2019-2030)
2.7 South Korea Remimazolam Consumption (2019-2030)
2.8 ASEAN Remimazolam Consumption (2019-2030)
2.9 India Remimazolam Consumption (2019-2030)

3 World Remimazolam Manufacturers Competitive Analysis
3.1 World Remimazolam Production Value by Manufacturer (2019-2024)
3.2 World Remimazolam Production by Manufacturer (2019-2024)
3.3 World Remimazolam Average Price by Manufacturer (2019-2024)
3.4 Remimazolam Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Remimazolam Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Remimazolam in 2023
3.5.3 Global Concentration Ratios (CR8) for Remimazolam in 2023
3.6 Remimazolam Market: Overall Company Footprint Analysis
3.6.1 Remimazolam Market: Region Footprint
3.6.2 Remimazolam Market: Company Product Type Footprint
3.6.3 Remimazolam Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Remimazolam Production Value Comparison
4.1.1 United States VS China: Remimazolam Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Remimazolam Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Remimazolam Production Comparison
4.2.1 United States VS China: Remimazolam Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Remimazolam Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Remimazolam Consumption Comparison
4.3.1 United States VS China: Remimazolam Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Remimazolam Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Remimazolam Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Remimazolam Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Remimazolam Production Value (2019-2024)
4.4.3 United States Based Manufacturers Remimazolam Production (2019-2024)
4.5 China Based Remimazolam Manufacturers and Market Share
4.5.1 China Based Remimazolam Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Remimazolam Production Value (2019-2024)
4.5.3 China Based Manufacturers Remimazolam Production (2019-2024)
4.6 Rest of World Based Remimazolam Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Remimazolam Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Remimazolam Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Remimazolam Production (2019-2024)

5 Market Analysis by Type
5.1 World Remimazolam Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 2.5mg
5.2.2 20mg
5.3 Market Segment by Type
5.3.1 World Remimazolam Production by Type (2019-2030)
5.3.2 World Remimazolam Production Value by Type (2019-2030)
5.3.3 World Remimazolam Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Remimazolam Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Surgical Anesthesia
6.2.2 ICU Sedation
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Remimazolam Production by Application (2019-2030)
6.3.2 World Remimazolam Production Value by Application (2019-2030)
6.3.3 World Remimazolam Average Price by Application (2019-2030)

7 Company Profiles
7.1 Paion
7.1.1 Paion Details
7.1.2 Paion Major Business
7.1.3 Paion Remimazolam Product and Services
7.1.4 Paion Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Paion Recent Developments/Updates
7.1.6 Paion Competitive Strengths & Weaknesses
7.2 Yichang Renfu Pharmaceutical
7.2.1 Yichang Renfu Pharmaceutical Details
7.2.2 Yichang Renfu Pharmaceutical Major Business
7.2.3 Yichang Renfu Pharmaceutical Remimazolam Product and Services
7.2.4 Yichang Renfu Pharmaceutical Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Yichang Renfu Pharmaceutical Recent Developments/Updates
7.2.6 Yichang Renfu Pharmaceutical Competitive Strengths & Weaknesses
7.3 Jiangsu Hengrui Medicine
7.3.1 Jiangsu Hengrui Medicine Details
7.3.2 Jiangsu Hengrui Medicine Major Business
7.3.3 Jiangsu Hengrui Medicine Remimazolam Product and Services
7.3.4 Jiangsu Hengrui Medicine Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Jiangsu Hengrui Medicine Recent Developments/Updates
7.3.6 Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
7.4 Cosmo Pharmaceuticals
7.4.1 Cosmo Pharmaceuticals Details
7.4.2 Cosmo Pharmaceuticals Major Business
7.4.3 Cosmo Pharmaceuticals Remimazolam Product and Services
7.4.4 Cosmo Pharmaceuticals Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Cosmo Pharmaceuticals Recent Developments/Updates
7.4.6 Cosmo Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Mundipharma
7.5.1 Mundipharma Details
7.5.2 Mundipharma Major Business
7.5.3 Mundipharma Remimazolam Product and Services
7.5.4 Mundipharma Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Mundipharma Recent Developments/Updates
7.5.6 Mundipharma Competitive Strengths & Weaknesses
7.6 Pharmascience
7.6.1 Pharmascience Details
7.6.2 Pharmascience Major Business
7.6.3 Pharmascience Remimazolam Product and Services
7.6.4 Pharmascience Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Pharmascience Recent Developments/Updates
7.6.6 Pharmascience Competitive Strengths & Weaknesses
7.7 Hana Pharm
7.7.1 Hana Pharm Details
7.7.2 Hana Pharm Major Business
7.7.3 Hana Pharm Remimazolam Product and Services
7.7.4 Hana Pharm Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Hana Pharm Recent Developments/Updates
7.7.6 Hana Pharm Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Remimazolam Industry Chain
8.2 Remimazolam Upstream Analysis
8.2.1 Remimazolam Core Raw Materials
8.2.2 Main Manufacturers of Remimazolam Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Remimazolam Production Mode
8.6 Remimazolam Procurement Model
8.7 Remimazolam Industry Sales Model and Sales Channels
8.7.1 Remimazolam Sales Model
8.7.2 Remimazolam Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Remimazolam Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Remimazolam Production Value by Region (2019-2024) & (USD Million)
Table 3. World Remimazolam Production Value by Region (2025-2030) & (USD Million)
Table 4. World Remimazolam Production Value Market Share by Region (2019-2024)
Table 5. World Remimazolam Production Value Market Share by Region (2025-2030)
Table 6. World Remimazolam Production by Region (2019-2024) & (K Units)
Table 7. World Remimazolam Production by Region (2025-2030) & (K Units)
Table 8. World Remimazolam Production Market Share by Region (2019-2024)
Table 9. World Remimazolam Production Market Share by Region (2025-2030)
Table 10. World Remimazolam Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Remimazolam Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Remimazolam Major Market Trends
Table 13. World Remimazolam Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Remimazolam Consumption by Region (2019-2024) & (K Units)
Table 15. World Remimazolam Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Remimazolam Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Remimazolam Producers in 2023
Table 18. World Remimazolam Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Remimazolam Producers in 2023
Table 20. World Remimazolam Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Remimazolam Company Evaluation Quadrant
Table 22. World Remimazolam Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Remimazolam Production Site of Key Manufacturer
Table 24. Remimazolam Market: Company Product Type Footprint
Table 25. Remimazolam Market: Company Product Application Footprint
Table 26. Remimazolam Competitive Factors
Table 27. Remimazolam New Entrant and Capacity Expansion Plans
Table 28. Remimazolam Mergers & Acquisitions Activity
Table 29. United States VS China Remimazolam Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Remimazolam Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Remimazolam Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Remimazolam Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Remimazolam Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Remimazolam Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Remimazolam Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Remimazolam Production Market Share (2019-2024)
Table 37. China Based Remimazolam Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Remimazolam Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Remimazolam Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Remimazolam Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Remimazolam Production Market Share (2019-2024)
Table 42. Rest of World Based Remimazolam Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Remimazolam Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Remimazolam Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Remimazolam Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Remimazolam Production Market Share (2019-2024)
Table 47. World Remimazolam Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Remimazolam Production by Type (2019-2024) & (K Units)
Table 49. World Remimazolam Production by Type (2025-2030) & (K Units)
Table 50. World Remimazolam Production Value by Type (2019-2024) & (USD Million)
Table 51. World Remimazolam Production Value by Type (2025-2030) & (USD Million)
Table 52. World Remimazolam Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Remimazolam Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Remimazolam Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Remimazolam Production by Application (2019-2024) & (K Units)
Table 56. World Remimazolam Production by Application (2025-2030) & (K Units)
Table 57. World Remimazolam Production Value by Application (2019-2024) & (USD Million)
Table 58. World Remimazolam Production Value by Application (2025-2030) & (USD Million)
Table 59. World Remimazolam Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Remimazolam Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Paion Basic Information, Manufacturing Base and Competitors
Table 62. Paion Major Business
Table 63. Paion Remimazolam Product and Services
Table 64. Paion Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Paion Recent Developments/Updates
Table 66. Paion Competitive Strengths & Weaknesses
Table 67. Yichang Renfu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Yichang Renfu Pharmaceutical Major Business
Table 69. Yichang Renfu Pharmaceutical Remimazolam Product and Services
Table 70. Yichang Renfu Pharmaceutical Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Yichang Renfu Pharmaceutical Recent Developments/Updates
Table 72. Yichang Renfu Pharmaceutical Competitive Strengths & Weaknesses
Table 73. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 74. Jiangsu Hengrui Medicine Major Business
Table 75. Jiangsu Hengrui Medicine Remimazolam Product and Services
Table 76. Jiangsu Hengrui Medicine Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 78. Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
Table 79. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Cosmo Pharmaceuticals Major Business
Table 81. Cosmo Pharmaceuticals Remimazolam Product and Services
Table 82. Cosmo Pharmaceuticals Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Cosmo Pharmaceuticals Recent Developments/Updates
Table 84. Cosmo Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 86. Mundipharma Major Business
Table 87. Mundipharma Remimazolam Product and Services
Table 88. Mundipharma Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Mundipharma Recent Developments/Updates
Table 90. Mundipharma Competitive Strengths & Weaknesses
Table 91. Pharmascience Basic Information, Manufacturing Base and Competitors
Table 92. Pharmascience Major Business
Table 93. Pharmascience Remimazolam Product and Services
Table 94. Pharmascience Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Pharmascience Recent Developments/Updates
Table 96. Hana Pharm Basic Information, Manufacturing Base and Competitors
Table 97. Hana Pharm Major Business
Table 98. Hana Pharm Remimazolam Product and Services
Table 99. Hana Pharm Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 100. Global Key Players of Remimazolam Upstream (Raw Materials)
Table 101. Remimazolam Typical Customers
Table 102. Remimazolam Typical Distributors
List of Figure
Figure 1. Remimazolam Picture
Figure 2. World Remimazolam Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Remimazolam Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Remimazolam Production (2019-2030) & (K Units)
Figure 5. World Remimazolam Average Price (2019-2030) & (US$/Unit)
Figure 6. World Remimazolam Production Value Market Share by Region (2019-2030)
Figure 7. World Remimazolam Production Market Share by Region (2019-2030)
Figure 8. North America Remimazolam Production (2019-2030) & (K Units)
Figure 9. Europe Remimazolam Production (2019-2030) & (K Units)
Figure 10. China Remimazolam Production (2019-2030) & (K Units)
Figure 11. Japan Remimazolam Production (2019-2030) & (K Units)
Figure 12. Remimazolam Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Remimazolam Consumption (2019-2030) & (K Units)
Figure 15. World Remimazolam Consumption Market Share by Region (2019-2030)
Figure 16. United States Remimazolam Consumption (2019-2030) & (K Units)
Figure 17. China Remimazolam Consumption (2019-2030) & (K Units)
Figure 18. Europe Remimazolam Consumption (2019-2030) & (K Units)
Figure 19. Japan Remimazolam Consumption (2019-2030) & (K Units)
Figure 20. South Korea Remimazolam Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Remimazolam Consumption (2019-2030) & (K Units)
Figure 22. India Remimazolam Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Remimazolam by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Remimazolam Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Remimazolam Markets in 2023
Figure 26. United States VS China: Remimazolam Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Remimazolam Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Remimazolam Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Remimazolam Production Market Share 2023
Figure 30. China Based Manufacturers Remimazolam Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Remimazolam Production Market Share 2023
Figure 32. World Remimazolam Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Remimazolam Production Value Market Share by Type in 2023
Figure 34. 2.5mg
Figure 35. 20mg
Figure 36. World Remimazolam Production Market Share by Type (2019-2030)
Figure 37. World Remimazolam Production Value Market Share by Type (2019-2030)
Figure 38. World Remimazolam Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Remimazolam Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Remimazolam Production Value Market Share by Application in 2023
Figure 41. Surgical Anesthesia
Figure 42. ICU Sedation
Figure 43. Other
Figure 44. World Remimazolam Production Market Share by Application (2019-2030)
Figure 45. World Remimazolam Production Value Market Share by Application (2019-2030)
Figure 46. World Remimazolam Average Price by Application (2019-2030) & (US$/Unit)
Figure 47. Remimazolam Industry Chain
Figure 48. Remimazolam Procurement Model
Figure 49. Remimazolam Sales Model
Figure 50. Remimazolam Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Paion
Yichang Renfu Pharmaceutical
Jiangsu Hengrui Medicine
Cosmo Pharmaceuticals
Mundipharma
Pharmascience
Hana Pharm
btl

Related Reports

Global Remimazolam Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 xian22

Global Remimazolam Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 10 Jan 2023

date Pharma & Healthcare

Remimazolam, sold under the brand name Byfavo, is a medication for the induction and maintenance of procedural sedation in adults for invasive diagnostic or surgical procedures lasting 30 minutes or less. is a benzodiazepine drug, developed by PAION AG in collaboration with several regional licensees as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in the induction of anesthesia and conscious sedation for minor invasive procedures. Remimazolam was found to have both a more rapid onset and a shorter duration than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Remimazolam Supply, Demand and Key Producers, 2024-2030

Global Remimazolam Supply, Demand and Key Producers, 2024-2030

Page: 109

Published Date: 29 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Remimazolam market size is expected to reach $ 619.7 million by 2030, rising at a market growth of 5.1% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Remimazolam, sold under the brand name Byfavo, is a medication for the induction and maintenance of procedural sedation in adults for invasive diagnostic or surgical procedures lasting 30 minutes or less. is a benzodiazepine drug, developed by PAION AG in collaboration with several regional licensees as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in the induction of anesthesia and conscious sedation for minor invasive procedures. Remimazolam was found to have both a more rapid onset and a shorter duration than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.

This report studies the global Remimazolam production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Remimazolam, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Remimazolam that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Remimazolam total production and demand, 2019-2030, (K Units)
Global Remimazolam total production value, 2019-2030, (USD Million)
Global Remimazolam production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Remimazolam consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Remimazolam domestic production, consumption, key domestic manufacturers and share
Global Remimazolam production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Remimazolam production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Remimazolam production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Remimazolam market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Paion, Yichang Renfu Pharmaceutical, Jiangsu Hengrui Medicine, Cosmo Pharmaceuticals, Mundipharma, Pharmascience and Hana Pharm, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Remimazolam market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Remimazolam Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Remimazolam Market, Segmentation by Type
2.5mg
20mg

Global Remimazolam Market, Segmentation by Application
Surgical Anesthesia
ICU Sedation
Other

Companies Profiled:
Paion
Yichang Renfu Pharmaceutical
Jiangsu Hengrui Medicine
Cosmo Pharmaceuticals
Mundipharma
Pharmascience
Hana Pharm

Key Questions Answered
1. How big is the global Remimazolam market?
2. What is the demand of the global Remimazolam market?
3. What is the year over year growth of the global Remimazolam market?
4. What is the production and production value of the global Remimazolam market?
5. Who are the key producers in the global Remimazolam market?
btl

Table of Contents

1 Supply Summary
1.1 Remimazolam Introduction
1.2 World Remimazolam Supply & Forecast
1.2.1 World Remimazolam Production Value (2019 & 2023 & 2030)
1.2.2 World Remimazolam Production (2019-2030)
1.2.3 World Remimazolam Pricing Trends (2019-2030)
1.3 World Remimazolam Production by Region (Based on Production Site)
1.3.1 World Remimazolam Production Value by Region (2019-2030)
1.3.2 World Remimazolam Production by Region (2019-2030)
1.3.3 World Remimazolam Average Price by Region (2019-2030)
1.3.4 North America Remimazolam Production (2019-2030)
1.3.5 Europe Remimazolam Production (2019-2030)
1.3.6 China Remimazolam Production (2019-2030)
1.3.7 Japan Remimazolam Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Remimazolam Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Remimazolam Major Market Trends

2 Demand Summary
2.1 World Remimazolam Demand (2019-2030)
2.2 World Remimazolam Consumption by Region
2.2.1 World Remimazolam Consumption by Region (2019-2024)
2.2.2 World Remimazolam Consumption Forecast by Region (2025-2030)
2.3 United States Remimazolam Consumption (2019-2030)
2.4 China Remimazolam Consumption (2019-2030)
2.5 Europe Remimazolam Consumption (2019-2030)
2.6 Japan Remimazolam Consumption (2019-2030)
2.7 South Korea Remimazolam Consumption (2019-2030)
2.8 ASEAN Remimazolam Consumption (2019-2030)
2.9 India Remimazolam Consumption (2019-2030)

3 World Remimazolam Manufacturers Competitive Analysis
3.1 World Remimazolam Production Value by Manufacturer (2019-2024)
3.2 World Remimazolam Production by Manufacturer (2019-2024)
3.3 World Remimazolam Average Price by Manufacturer (2019-2024)
3.4 Remimazolam Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Remimazolam Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Remimazolam in 2023
3.5.3 Global Concentration Ratios (CR8) for Remimazolam in 2023
3.6 Remimazolam Market: Overall Company Footprint Analysis
3.6.1 Remimazolam Market: Region Footprint
3.6.2 Remimazolam Market: Company Product Type Footprint
3.6.3 Remimazolam Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Remimazolam Production Value Comparison
4.1.1 United States VS China: Remimazolam Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Remimazolam Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Remimazolam Production Comparison
4.2.1 United States VS China: Remimazolam Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Remimazolam Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Remimazolam Consumption Comparison
4.3.1 United States VS China: Remimazolam Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Remimazolam Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Remimazolam Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Remimazolam Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Remimazolam Production Value (2019-2024)
4.4.3 United States Based Manufacturers Remimazolam Production (2019-2024)
4.5 China Based Remimazolam Manufacturers and Market Share
4.5.1 China Based Remimazolam Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Remimazolam Production Value (2019-2024)
4.5.3 China Based Manufacturers Remimazolam Production (2019-2024)
4.6 Rest of World Based Remimazolam Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Remimazolam Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Remimazolam Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Remimazolam Production (2019-2024)

5 Market Analysis by Type
5.1 World Remimazolam Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 2.5mg
5.2.2 20mg
5.3 Market Segment by Type
5.3.1 World Remimazolam Production by Type (2019-2030)
5.3.2 World Remimazolam Production Value by Type (2019-2030)
5.3.3 World Remimazolam Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Remimazolam Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Surgical Anesthesia
6.2.2 ICU Sedation
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Remimazolam Production by Application (2019-2030)
6.3.2 World Remimazolam Production Value by Application (2019-2030)
6.3.3 World Remimazolam Average Price by Application (2019-2030)

7 Company Profiles
7.1 Paion
7.1.1 Paion Details
7.1.2 Paion Major Business
7.1.3 Paion Remimazolam Product and Services
7.1.4 Paion Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Paion Recent Developments/Updates
7.1.6 Paion Competitive Strengths & Weaknesses
7.2 Yichang Renfu Pharmaceutical
7.2.1 Yichang Renfu Pharmaceutical Details
7.2.2 Yichang Renfu Pharmaceutical Major Business
7.2.3 Yichang Renfu Pharmaceutical Remimazolam Product and Services
7.2.4 Yichang Renfu Pharmaceutical Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Yichang Renfu Pharmaceutical Recent Developments/Updates
7.2.6 Yichang Renfu Pharmaceutical Competitive Strengths & Weaknesses
7.3 Jiangsu Hengrui Medicine
7.3.1 Jiangsu Hengrui Medicine Details
7.3.2 Jiangsu Hengrui Medicine Major Business
7.3.3 Jiangsu Hengrui Medicine Remimazolam Product and Services
7.3.4 Jiangsu Hengrui Medicine Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Jiangsu Hengrui Medicine Recent Developments/Updates
7.3.6 Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
7.4 Cosmo Pharmaceuticals
7.4.1 Cosmo Pharmaceuticals Details
7.4.2 Cosmo Pharmaceuticals Major Business
7.4.3 Cosmo Pharmaceuticals Remimazolam Product and Services
7.4.4 Cosmo Pharmaceuticals Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Cosmo Pharmaceuticals Recent Developments/Updates
7.4.6 Cosmo Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Mundipharma
7.5.1 Mundipharma Details
7.5.2 Mundipharma Major Business
7.5.3 Mundipharma Remimazolam Product and Services
7.5.4 Mundipharma Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Mundipharma Recent Developments/Updates
7.5.6 Mundipharma Competitive Strengths & Weaknesses
7.6 Pharmascience
7.6.1 Pharmascience Details
7.6.2 Pharmascience Major Business
7.6.3 Pharmascience Remimazolam Product and Services
7.6.4 Pharmascience Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Pharmascience Recent Developments/Updates
7.6.6 Pharmascience Competitive Strengths & Weaknesses
7.7 Hana Pharm
7.7.1 Hana Pharm Details
7.7.2 Hana Pharm Major Business
7.7.3 Hana Pharm Remimazolam Product and Services
7.7.4 Hana Pharm Remimazolam Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Hana Pharm Recent Developments/Updates
7.7.6 Hana Pharm Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Remimazolam Industry Chain
8.2 Remimazolam Upstream Analysis
8.2.1 Remimazolam Core Raw Materials
8.2.2 Main Manufacturers of Remimazolam Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Remimazolam Production Mode
8.6 Remimazolam Procurement Model
8.7 Remimazolam Industry Sales Model and Sales Channels
8.7.1 Remimazolam Sales Model
8.7.2 Remimazolam Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Remimazolam Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Remimazolam Production Value by Region (2019-2024) & (USD Million)
Table 3. World Remimazolam Production Value by Region (2025-2030) & (USD Million)
Table 4. World Remimazolam Production Value Market Share by Region (2019-2024)
Table 5. World Remimazolam Production Value Market Share by Region (2025-2030)
Table 6. World Remimazolam Production by Region (2019-2024) & (K Units)
Table 7. World Remimazolam Production by Region (2025-2030) & (K Units)
Table 8. World Remimazolam Production Market Share by Region (2019-2024)
Table 9. World Remimazolam Production Market Share by Region (2025-2030)
Table 10. World Remimazolam Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Remimazolam Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Remimazolam Major Market Trends
Table 13. World Remimazolam Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Remimazolam Consumption by Region (2019-2024) & (K Units)
Table 15. World Remimazolam Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Remimazolam Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Remimazolam Producers in 2023
Table 18. World Remimazolam Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Remimazolam Producers in 2023
Table 20. World Remimazolam Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Remimazolam Company Evaluation Quadrant
Table 22. World Remimazolam Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Remimazolam Production Site of Key Manufacturer
Table 24. Remimazolam Market: Company Product Type Footprint
Table 25. Remimazolam Market: Company Product Application Footprint
Table 26. Remimazolam Competitive Factors
Table 27. Remimazolam New Entrant and Capacity Expansion Plans
Table 28. Remimazolam Mergers & Acquisitions Activity
Table 29. United States VS China Remimazolam Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Remimazolam Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Remimazolam Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Remimazolam Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Remimazolam Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Remimazolam Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Remimazolam Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Remimazolam Production Market Share (2019-2024)
Table 37. China Based Remimazolam Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Remimazolam Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Remimazolam Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Remimazolam Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Remimazolam Production Market Share (2019-2024)
Table 42. Rest of World Based Remimazolam Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Remimazolam Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Remimazolam Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Remimazolam Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Remimazolam Production Market Share (2019-2024)
Table 47. World Remimazolam Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Remimazolam Production by Type (2019-2024) & (K Units)
Table 49. World Remimazolam Production by Type (2025-2030) & (K Units)
Table 50. World Remimazolam Production Value by Type (2019-2024) & (USD Million)
Table 51. World Remimazolam Production Value by Type (2025-2030) & (USD Million)
Table 52. World Remimazolam Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Remimazolam Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Remimazolam Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Remimazolam Production by Application (2019-2024) & (K Units)
Table 56. World Remimazolam Production by Application (2025-2030) & (K Units)
Table 57. World Remimazolam Production Value by Application (2019-2024) & (USD Million)
Table 58. World Remimazolam Production Value by Application (2025-2030) & (USD Million)
Table 59. World Remimazolam Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Remimazolam Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Paion Basic Information, Manufacturing Base and Competitors
Table 62. Paion Major Business
Table 63. Paion Remimazolam Product and Services
Table 64. Paion Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Paion Recent Developments/Updates
Table 66. Paion Competitive Strengths & Weaknesses
Table 67. Yichang Renfu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Yichang Renfu Pharmaceutical Major Business
Table 69. Yichang Renfu Pharmaceutical Remimazolam Product and Services
Table 70. Yichang Renfu Pharmaceutical Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Yichang Renfu Pharmaceutical Recent Developments/Updates
Table 72. Yichang Renfu Pharmaceutical Competitive Strengths & Weaknesses
Table 73. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 74. Jiangsu Hengrui Medicine Major Business
Table 75. Jiangsu Hengrui Medicine Remimazolam Product and Services
Table 76. Jiangsu Hengrui Medicine Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 78. Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
Table 79. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Cosmo Pharmaceuticals Major Business
Table 81. Cosmo Pharmaceuticals Remimazolam Product and Services
Table 82. Cosmo Pharmaceuticals Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Cosmo Pharmaceuticals Recent Developments/Updates
Table 84. Cosmo Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 86. Mundipharma Major Business
Table 87. Mundipharma Remimazolam Product and Services
Table 88. Mundipharma Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Mundipharma Recent Developments/Updates
Table 90. Mundipharma Competitive Strengths & Weaknesses
Table 91. Pharmascience Basic Information, Manufacturing Base and Competitors
Table 92. Pharmascience Major Business
Table 93. Pharmascience Remimazolam Product and Services
Table 94. Pharmascience Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Pharmascience Recent Developments/Updates
Table 96. Hana Pharm Basic Information, Manufacturing Base and Competitors
Table 97. Hana Pharm Major Business
Table 98. Hana Pharm Remimazolam Product and Services
Table 99. Hana Pharm Remimazolam Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 100. Global Key Players of Remimazolam Upstream (Raw Materials)
Table 101. Remimazolam Typical Customers
Table 102. Remimazolam Typical Distributors
List of Figure
Figure 1. Remimazolam Picture
Figure 2. World Remimazolam Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Remimazolam Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Remimazolam Production (2019-2030) & (K Units)
Figure 5. World Remimazolam Average Price (2019-2030) & (US$/Unit)
Figure 6. World Remimazolam Production Value Market Share by Region (2019-2030)
Figure 7. World Remimazolam Production Market Share by Region (2019-2030)
Figure 8. North America Remimazolam Production (2019-2030) & (K Units)
Figure 9. Europe Remimazolam Production (2019-2030) & (K Units)
Figure 10. China Remimazolam Production (2019-2030) & (K Units)
Figure 11. Japan Remimazolam Production (2019-2030) & (K Units)
Figure 12. Remimazolam Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Remimazolam Consumption (2019-2030) & (K Units)
Figure 15. World Remimazolam Consumption Market Share by Region (2019-2030)
Figure 16. United States Remimazolam Consumption (2019-2030) & (K Units)
Figure 17. China Remimazolam Consumption (2019-2030) & (K Units)
Figure 18. Europe Remimazolam Consumption (2019-2030) & (K Units)
Figure 19. Japan Remimazolam Consumption (2019-2030) & (K Units)
Figure 20. South Korea Remimazolam Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Remimazolam Consumption (2019-2030) & (K Units)
Figure 22. India Remimazolam Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Remimazolam by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Remimazolam Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Remimazolam Markets in 2023
Figure 26. United States VS China: Remimazolam Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Remimazolam Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Remimazolam Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Remimazolam Production Market Share 2023
Figure 30. China Based Manufacturers Remimazolam Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Remimazolam Production Market Share 2023
Figure 32. World Remimazolam Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Remimazolam Production Value Market Share by Type in 2023
Figure 34. 2.5mg
Figure 35. 20mg
Figure 36. World Remimazolam Production Market Share by Type (2019-2030)
Figure 37. World Remimazolam Production Value Market Share by Type (2019-2030)
Figure 38. World Remimazolam Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Remimazolam Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Remimazolam Production Value Market Share by Application in 2023
Figure 41. Surgical Anesthesia
Figure 42. ICU Sedation
Figure 43. Other
Figure 44. World Remimazolam Production Market Share by Application (2019-2030)
Figure 45. World Remimazolam Production Value Market Share by Application (2019-2030)
Figure 46. World Remimazolam Average Price by Application (2019-2030) & (US$/Unit)
Figure 47. Remimazolam Industry Chain
Figure 48. Remimazolam Procurement Model
Figure 49. Remimazolam Sales Model
Figure 50. Remimazolam Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Paion
Yichang Renfu Pharmaceutical
Jiangsu Hengrui Medicine
Cosmo Pharmaceuticals
Mundipharma
Pharmascience
Hana Pharm
btl

Related Reports

Global Remimazolam Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 xian22
q3

Global Remimazolam Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

industry 10 Jan 2023

industry Pharma & Healthcare

Remimazolam, sold under the brand name Byfavo, is a medication for the induction and maintenance of procedural sedation in adults for invasive diagnostic or surgical procedures lasting 30 minutes or less. is a benzodiazepine drug, developed by PAION AG in collaboration with several regional licensees as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in the induction of anesthesia and conscious sedation for minor invasive procedures. Remimazolam was found to have both a more rapid onset and a shorter duration than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.

jiaGou

Add To Cart

gouMai

Buy Now